Active ingredientFlutamideCat. No. P-F103-001CAS 13311-84-7Family · Pharmaceutical analytical standards
Flutamide
The first non-steroidal antiandrogen: synthesised in 1967 and first marketed in 1983 (in the United States in 1989), it blocks the action of testosterone and is used in prostate cancer. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It was originally synthesised as a bacteriostatic agent, against bacteria: its antiandrogen activity was only discovered later, by chance.
Go to the active ingredient →Active ingredientFlutamideCat. No. P-F103-001CAS 13311-84-7
Pharmacopoeial impurityFlutamide EP Impurity ACat. No. P-F103-002CAS 393-11-3
Pharmacopoeial impurityFlutamide EP Impurity BCat. No. P-F103-003CAS 393-12-4
Pharmacopoeial impurityFlutamide EP Impurity CCat. No. P-F103-004CAS 13312-12-4
Pharmacopoeial impurityFlutamide EP Impurity ECat. No. P-F103-005CAS 1939-27-1
Pharmacopoeial impurityFlutamide EP Impurity FCat. No. P-F103-006CAS 151262-93-0
Isotopically labelledFlutamide-d7Cat. No. P-F103-007CAS 223134-72-3
Isotopically labelledHydroxy Flutamide-d6Cat. No. P-F103-008CAS 223134-73-4
Impurity2-NitrobenzotrifluorideCat. No. P-F103-009CAS 384-22-5
Impurity3-NitrobenzotrifluorideCat. No. P-F103-010CAS 98-46-4
Impurity3-Trifluoromethyl-4-nitrophenolCat. No. P-F103-011CAS 88-30-2
ImpurityHydroxy FlutamideCat. No. P-F103-013CAS 52806-53-8
ImpurityTrifluoromethylbenzeneCat. No. P-F103-014CAS 98-08-8No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceFlutamide CRSEDQM code F0285600Family FlutamideNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.